Search results
Results from the WOW.Com Content Network
In August 2015, Insys Therapeutics reached a $1.1 million settlement with the Oregon Department of Justice, resolving allegations that it promoted its opioid drug Subsys to treat off-label non-cancer uses that were not approved by the FDA. [46] Insys has also paid New Hampshire $2.9 million to settle allegations of aggressive marketing of ...
King v. Burwell, 576 U.S. 473 (2015), was a 6–3 decision by the Supreme Court of the United States interpreting provisions of the Patient Protection and Affordable Care Act (ACA).
Finasteride, sold under the brand names Proscar and Propecia among others, is a medication used to treat pattern hair loss and benign prostatic hyperplasia (BPH) in men. [6] It can also be used to treat excessive hair growth in women [ 7 ] and as gender-affirming treatment in trans women . [ 8 ]
The lawsuits drove the company to declare bankruptcy in 1995, before it agreed to pay $2.3 billion to settle claims from 240,000 women in amounts ranging from $2,000 to $250,000 each in 2004 ...
Then came finasteride, a medication for treating hair loss that gained approval from the Federal Drug Administration (FDA) in 1997 as brand-name Propecia®. How Long Do Finasteride Results for ...
It’s sold as a generic and under the brand names Propecia and Proscar. As a 5-alpha-reductase inhibitor, finasteride works by inhibiting the effects of the enzyme responsible for converting ...
The following is a list of the 21 largest civil settlements, reached between the United States Department of Justice and pharmaceutical companies from 2001 to 2017, ordered by the size of the total civil settlement.
The 2015 term of the Supreme Court of the United States began October 5, 2015, and concluded October 2, 2016. The table below illustrates which opinion was filed by each justice in each case and which justices joined each opinion.